Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_3
4
80%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (20.0%)
Phase 34 (80.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_2

Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer

NCT03583593
completedphase_3

Diamel in the Treatment of Polycystic Ovary Syndrome

NCT01051024
completedphase_3

Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis

NCT00820651
completedphase_3

Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy

NCT00994266
completedphase_3

Diamel in the Treatment of Metabolic Syndrome

NCT01025115

Clinical Trials (5)

Showing 5 of 5 trials
NCT03583593Phase 2

Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer

Completed
NCT01051024Phase 3

Diamel in the Treatment of Polycystic Ovary Syndrome

Completed
NCT00820651Phase 3

Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis

Completed
NCT00994266Phase 3

Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy

Completed
NCT01025115Phase 3

Diamel in the Treatment of Metabolic Syndrome

Completed

All 5 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
5